Find alternative funding ways to set up new NIPERs: Parl Panel directs DoP
A Parliamentary panel on Monday asked the Department of Pharmaceuticals to explore alternative ways of funding, including contribution from state governments, to set up five new NIPERs in the country.;
New Delhi: A Parliamentary panel on Monday asked the Department of Pharmaceuticals (DoP) to explore alternative ways of funding, including contribution from state governments, to set up five new National Institute of Pharmaceutical Education and Research (NIPERs) in the country. The Standing Committee on Chemicals and Fertilisers said it is constrained to note that the proposal to set up five new NIPERs in Tamil Nadu, Karnataka, Chhattisgarh, Rajasthan and Maharashtra is still on paper without any concrete action to set them up. The DoP had asked the Expenditure Finance Committee (EFC) to allocate Rs 4,300 crore for the existing seven NIPERs and additional five NIPERs for the next five years. However, EFC has earmarked only Rs 1,500 crore for NIPERs with the rider that this allocation should be utilized only for the existing seven NIPERs. In this regard, the DoP now proposed to explore alternative ways of funding these NIPERs, it added.
The committee noted that the existing seven NIPERs were hardly sufficient to meet the requirements of the country in the field of pharmaceutical education and research.
Further, the panel strongly recommended that all necessary steps should be taken by the DoP for the early setting up of five new NIPERs. "In this regard, a fresh proposal may be submitted to EFC for reconsideration of their decision and the concern expressed by this committee may be conveyed to them.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.